Prostate cancer vaccine costs $93K: Another Reason For Rising Health Care Costs
Provenge can improve survival just by about four months, and it comes with a hefty, $93,000 price tag for a three-step treatment. The Centers for Medicare and Medicaid Services this week will conduct a hearing to determine if it will cover the treatment. Patient advocates say it is frustrating that keeping someone alive could be reduced to a money decision.
“This is a very scary type of discussion that’s being had, and I can guarantee you that if Provenge was a $1,000 drug instead of $100,000, this discussion would not be happening whatsoever,” said Skip Lockwood, CEO of Zero: The Project to End Prostate Cancer…